UNDA 248 (Seroyal USA)


Welcome to the PulseAid listing for the UNDA 248 drug offered from Seroyal USA. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: Seroyal USA
NON-PROPRIETARY NAME: Crataegus, Magnolia grandiflora, Passiflora incarnata, Strophanthus gratus
SUBSTANCE NAME: STROPHANTHUS GRATUS SEED; CRATAEGUS FRUIT; MAGNOLIA GRANDIFLORA FLOWER; PASSIFLORA INCARNATA FLOWERING TOP
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2017-07-04
END MARKETING DATE: 0000-00-00


UNDA 248 HUMAN OTC DRUG Details:

Item DescriptionUNDA 248 from Seroyal USA
LABELER NAME: Seroyal USA
DEA SCHEDULE:
ACTIVE STRENGTH: 4; 4; 4; 4([hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL; [hp_X]/20mL)
START MARKETING DATE: 2017-07-04
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62106-1164_5383e4f9-337b-74b5-e054-00144ff88e88
PRODUCT NDC: 62106-1164
APPLICATION NUMBER:

Other STROPHANTHUS GRATUS SEED; CRATAEGUS FRUIT; MAGNOLIA GRANDIFLORA FLOWER; PASSIFLORA INCARNATA FLOWERING TOP Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Seroyal USAUNDA 248